FDA Inspection 1015476 - Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - May 22, 2017
FDA Inspection 1015476 for Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on May 22, 2017. Classification: Official Action Indicated (OAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1015476 for Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on May 22, 2017. Classification: Official Action Indicated (OAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
May 22, 2017
Product Type
Drugs
ID: 2331290f-5f8e-4072-9e69-ab70fefd01fc
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox